Effectiveness of a structured motivational intervention including smoking cessation advice and spirometry information in the primary care setting: The ESPITAP study

BMC Public Health

Volumn 11, Issue , 2011, Pages

  Martin Lujan, Francisco ^a,b,c   Ll Pĩol Moreso, Josep ^a,b   Martin Vergara, Nuria ^a   Basora Gallisa, Josep ^a,b   Pascual Palacios, Irene ^a   Sagarra Alamo, Ramon ^a   Llopis, Estefania ^a   Basora Gallisa, Maria T ^a   Pedret Llaberia, Roser ^a  

^a Research Institute University Primary Care IDIAP Jordi Gol   (Spain)

^b UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^c C/Camí de Riudoms ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIRECTIVE COUNSELING; FOLLOW UP; HUMAN; METHODOLOGY; MIDDLE AGED; MOTIVATION; MULTICENTER STUDY; PRIMARY HEALTH CARE; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; SMOKING; SMOKING CESSATION; SPAIN; SPIROMETRY; STATISTICS; TREATMENT OUTCOME;

ADULT; AGED; DIRECTIVE COUNSELING; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; MOTIVATION; PRIMARY HEALTH CARE; SMOKING; SMOKING CESSATION; SPAIN; SPIROMETRY; TREATMENT OUTCOME;

EID: 81055134754     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-11-859     Document Type: Article

References (37)

1. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Global Initiative for Chronic Obstructive Lung Disease, NHLBI/WHO Workshop Report Reviewed 2010 http://www.goldcopd.org/
2. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Kohansal R, Martinez-Camblor P, Agustí A, Buist AS, Mannino DM, Soriano JB, Am J Respir Crit Care Med 2009 180 3 10 10.1164/rccm.200901-0047OC 19342411
3. Developing COPD: a 25 year follow up study of the general population. Lokke A, Lange P, Scharling H, Fabricius P, Vestbo J, Thorax 2006 61 935 939 10.1136/thx.2006.062802 17071833 (Pubitemid 44787161)
4. Epidemiology of COPD. Raherison C, Girodet PO, Eur Respir Rev 2009 18 213 221 10.1183/09059180.00003609 20956146
5. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Pauwels R, Buist A, Calverley P, Jenkins C, Hurd S, Am J Respir Crit Care Med 2001 163 1256 1276 11316667 (Pubitemid 32378468)
6. Diagnosis and management of chronic obstructive pulmonary disease: joint guidelines of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and the Latin American Thoracic Society (ALAT). Peces-Barba G, Barber JA, Agustí A, Casanova C, Casas A, Izquierdo JL, Jardim J, Lápez Varela V, Monsá E, Montemayor T, Viejo JL, Arch Bronconeumol 2008 44 271 281 18448019 (Pubitemid 351860078)
7. Screening for chronic obstructive pulmonary disease using spirometry: US preventive services Task Force recommendation statement. United States Preventive Services Task Force, Ann Intern Med 2008 148 529 533 18316747
8. Screening for chronic obstructive pulmonary disease using spirometry: summary of the evidence for the U.S. Preventive Services Task Force. Lin K, Watkins B, Johnson T, Rodriguez JA, Barton MB, Ann Intern Med 2008 148 535 543 18316746 (Pubitemid 351665424)
9. Evaluating primary care behavioral counseling interventions: an evidence-based approach. Whitlock EP, Orleans CT, Pender N, Allan J, Am J Prev Med 2002 22 267 284 10.1016/S0749-3797(02)00415-4 11988383 (Pubitemid 34436893)
10. Non-pharmacological smoking cessation interventions in clinical practice. Cornuz J, Willi C, Eur Respir Rev 2008 17 187 191 10.1183/09059180.00011003
11. Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD. Hoogendoorn M, Feenstra TL, Hoogenveen RT, Rutten-van Mölken MP, Thorax 2010 65 711 718 10.1136/thx.2009.131631 20685746
12. Treating tobacco use and dependence: 2008 update. Clinical practice guideline. Fiore MC, Jaen CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, Dorfman S, Froelicher E, Goldstein M, Healton C, Henderson P, Heyman R, Koh H, Kottke T, Lando H, Mecklenburg R, Mermelstein R, Mullen P, Orleans C, Robinson L, Stitzer M, Tommasello A, Villejo L, Wewers M, Rockville, MD: U.S. Department of Health and Human Services. Public Health Service 2008 http://www. surgeongeneral.gov/tobacco/treating-tobacco-use08.pdf
13. Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Ferguson GT, Enright PL, Buist AS, Higgins MW, Chest 2000 117 1146 1161 10.1378/chest.117.4.1146 10767253 (Pubitemid 30228377)
14. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, Conway WA Jr, Enright PL, Kanner RE, O'Hara P, JAMA 1994 272 1497 1505 10.1001/jama.272.19.1497 7966841 (Pubitemid 24340791)
15. Smoking and lung function of Lung Health Study participants after 11 years. Anthonisen NR, Connett JE, Murray RP, Am J Respir Crit Care Med 2002 166 675 679 10.1164/rccm.2112096 12204864 (Pubitemid 34971849)
16. Bronchodilator response in the lung health study over 11 years. Anthonisen NR, Lindgren PG, Tashkin DP, Kanner RE, Scanlon PD, Connett JE, Eur Respir J 2005 1 45 51 (Pubitemid 40945930)
17. Smokers with airway obstruction are more likely to quit smoking. Bednarek M, Gorecka D, Wielgomas J, Czajkowska-Malinowska M, Regula J, Mieszko-Filipczyk G, Jasionowicz M, Bijata-Bronisz R, Lempicka-Jastrzebska M, Czajkowski M, Przybylski G, Zielinski J, Thorax 2006 61 869 873 10.1136/thx.2006.059071 16809415 (Pubitemid 44570307)
18. The natural history of chronic airflow obstruction. Fletcher C, Peto R, BMJ 1977 1 1645 1648 10.1136/bmj.1.6077.1645 871704 (Pubitemid 8124466)
19. Spirometry for chronic obstructive pulmonary disease case finding in primary care? Boushey H, Enright P, Samet J, Am J Respir Crit Care Med 2005 172 1481 1482 10.1164/rccm.2509009 16339010 (Pubitemid 43076530)
20. Spirometry as a motivational tool to improve smoking cessation rates: a systematic review of the literature. Wilt TJ, Niewoehner D, Kane RL, MacDonald R, Joseph AM, Nicotine Tob Res 2007 9 21 32 10.1080/14622200601078509 17365733 (Pubitemid 47009041)
21. Biomedical risk assessment as an aid for smoking cessation. Bize R, Burnand B, Mueller Y, Rège Walther M, Cornuz J, Cochrane Database Syst Rev 2009 2 D004705
22. Effect of smoking on quit rate of telling patients their lung age: the Step2quit randomized controlled trial. Parkes G, Greenhalgh T, Griffin M, Dent R, BMJ 2008 336 598 600 10.1136/bmj.39503.582396.25 18326503 (Pubitemid 351439517)
23. Efficacy of confronting smokers with airflow limitation for smoking cessation. Kotz D, Wesseling G, Huibers MJH, van Schayck OCP, Eur Respir J 2009 33 754 762 10.1183/09031936.00116308 19129277
24. Impact of a brief motivational smoking cessation intervention: the Get PHIT trial. McClure JB, Ludman EJ, Grothaus L, Pabiniak C, Richards J, Am J Prev Med 2009 37 116 123 10.1016/j.amepre.2009.03.018 19524389
25. Impact of spirometry feedback and brief motivational counseling on long-term smoking outcomes: a comparison of smokers with and without lung impairment. McClure JB, Ludman EJ, Grothaus L, Pabiniak C, Richards J, Patient Educ Couns 2010 80 280 283 10.1016/j.pec.2009.11.002 20434863
26. The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Heatherton TF, Kozlowski LT, Frecker RC, Fageström KO, Br J Addict 1991 86 1119 1127 10.1111/j.1360-0443.1991. tb01879.x 1932883
27. Multivariate models for predicting abstention following intervention to stop smoking by general practitioners. Richmond RL, Kehoe LA, Webster IW, Addiction 1993 88 1127 1135 10.1111/j.1360-0443.1993.tb02132.x 8401167 (Pubitemid 23241979)
28. Stages and processes of self-change of smoking: toward an integrative model of change. Prochaska JO, DiClemente CC, J Consult Clin Psychol 1983 51 390 395 6863699
29. General considerations for lung function testing. Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, ATS/ERS Task Force, Eur Respir J 2005 26 153 161 10.1183/09031936.05.00034505 15994402 (Pubitemid 40945944)
30. Standardisation of spirometry. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, ATS/ERS Task Force, Eur Respir J 2005 26 319 338 10.1183/09031936.05.00034805 16055882 (Pubitemid 41079078)
31. Pruebas funcionales respiratorias en atencián primaria. Interpretacián informatizada de espirometrías. Martín F, Donado-Mazarrán A, Basora J, Daniel J, Form Med Contin Aten Prim 1999 6 161 172
32. Physician advice for smoking cessation. Stead LF, Bergson G, Lancaster T, Cochrane Database Syst Rev 2008 D000165
33. Spirometric "lung age" estimation for motivating smoking cessation. Morris JF, Temple W, Prev Med 1985 14 655 662 10.1016/0091-7435(85) 90085-4 4070195 (Pubitemid 16191244)
34. Optimal cutoff level of breath carbon monoxide for assessing smoking status in patients with asthma and COPD. Sato S, Nishimura K, Koyama H, Tsukino M, Oga T, Hajiro T, Mishima M, Chest 2003 124 1749 54 10.1378/chest.124.5.1749 14605044 (Pubitemid 37433568)
35. Measures of abstinence in clinical trials: issues and recommendations. Hughes J, Keely J, Niaura R, Ossip-Klein D, Richmond R, Swan G, Nicotine Tob Res 2003 5 13 26 12745503
36. Common predictors of smoking cessation in clinical practice. Caponnetto P, Polosa R, Respir Med 2008 102 1182 1192 10.1016/j.rmed.2008.02.017 18586479
37. Weekly versus basic smoking cessation support in primary care: a randomised controlled trial. Aveyard P, Brown K, Saunders C, Alexander A, Johnstone E, Munaf MR, Murphy M, Thorax 2007 62 898 903 10.1136/thx.2006.071837 17483139 (Pubitemid 47598355)